Answers are grounded in this paper and cite their sources.
in human rhabdomyosarcoma cells. An engineering "toolkit" was developed to enable easy use of the most extensively characterized of these new human sites, SHS231, located on the proximal long arm of chromosome 4. The target sites identified here have the potential to serve as additional human SHS to enable basic and clinical gene editing and genome-engineering applications.
No takes yet. Share an insight, caveat, or question.
Pellenz et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: